Proteomics Breakthrough

Photo: Courtesy of Pacific Northwest National Laboratory Measuring the faint expression of a low-level protein in a complex biological system is a bit like playing Where's Waldo in a moving picture with tens of thousands of extras. Without technology that can process the system quickly, accurately, and repeatedly, there's no telling how long each investigation will take. Scientists at the US Department of Energy's (DOE) Pacific Northwest National Laboratory (PNNL) in Richland, Wash., report t

Written byJane Salodof MacNeil
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Measuring the faint expression of a low-level protein in a complex biological system is a bit like playing Where's Waldo in a moving picture with tens of thousands of extras. Without technology that can process the system quickly, accurately, and repeatedly, there's no telling how long each investigation will take.

Scientists at the US Department of Energy's (DOE) Pacific Northwest National Laboratory (PNNL) in Richland, Wash., report they have an instrument that can do the job. Their protein mass spectrometer (PROMS) is the first high-throughput MS built expressly for proteomics. Richard D. Smith and his colleagues fashioned the prototype out of a 9.4-tesla Fourier-transform ion cyclotron resonance (FTICR) MS manufactured by Bruker Daltonics in Billerica, Mass.

As much as 100 times more sensitive than other methods for identifying proteins, PROMS can analyze results 10 to 100 times faster than a tandem MS, according to a PNNL announcement. "We're making measurements ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies